Objective. Although oral tolerance is a well-known phenomenon, the role of dendritic cells (DCs) is not well characterized. This study was conducted to better understand the differential role played by each Peyer's patch DC subset in the induction of oral tolerance to type II collagen (CII) in murine collagen-induced arthritis (CIA).Methods. CII was fed 6 times to DBA/1 mice beginning 2 weeks before immunization, and the effect on arthritis was assessed. We compared the proportion of CD11c؉,CD11b؉ DCs and CD11c؉,CD8␣؉ DCs in the Peyer's patches of CII-fed tolerized and phosphate buffered saline-fed nontolerized mice after the induction of CIA. The immunosuppressive properties of each DC subset were determined using fluorescenceactivated cell sorter analysis for intracellular interleukin-10 (IL-10) and IL-12 and mixed lymphocyte culture. The ability of each DC subset to induce CD4؉,CD25؉ T regulatory cells was also examined. Mice were injected with CII-pulsed CD11c؉,CD11b؉ DCs isolated from Peyer's patches of tolerized mice, and the effect on CIA was examined.Results. The severity of arthritis was significantly lower in tolerized mice. The proportion of CD11c؉,CD11b؉ DCs was increased in the Peyer's patches of tolerized mice and those DCs exhibited immunosuppressive characteristics, such as increased IL-10 production, inhibition of T cell proliferative responses to CII, and CD4؉,CD25؉ regulatory T cell induction. Furthermore, the CD11c؉,CD11b؉ DCs suppressed the severity of arthritis upon adoptive transfer.Conclusion. Our observations demonstrate that CD11c؉,CD11b؉ DCs, which are abundant in Peyer's patches during the induction of oral tolerance to CII, are crucial for the suppression of CIA and could be exploited for immunotherapy of autoimmune diseases.Oral tolerance refers to the immunologic hyporesponsiveness provoked by repeated exposure of the mucosal immune system to ingested protein antigens. Oral administration of antigens or peptides that are structurally similar to the autoantigen leads to local and systemic priming and, usually, to systemic tolerance, making this a promising approach for the treatment of autoimmune diseases. In animal models, it has been shown that oral tolerance effectively ameliorates experimental autoimmune encephalitis and collagen-induced arthritis (CIA) (1-8). Repeated oral administration of type II collagen (CII) induces peripheral immune tolerance, resulting in the suppression of CIA, a representative experimental model of human rheumatoid arthritis